Cormedix reported fourth quarter and full year 2024 financial results. During the Company’s earnings call held the same day, Cormedix noted that “we do expect to begin to see some net price erosion beginning in the second quarter of 2025.”
Following this news, the price of the Company’s stock dropped on March 25, 2025.
To receive more information, please fill out the form.
